Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 11.40%

Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has an Asset Resilience Ratio of 11.40% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Wantai Biological Pharmacy Enter (603392) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.56 Billion

≈ $228.73 Million USD Cash + Short-term Investments

Total Assets

CN¥13.71 Billion

≈ $2.01 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 603392 current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Beijing Wantai Biological Pharmacy Enterprise Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 603392 liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.56 Billion	11.4%
Total Liquid Assets	CN¥1.56 Billion	11.40%

Asset Resilience Insights

Moderate Liquidity: Beijing Wantai Biological Pharmacy Enterprise Co Ltd has 11.40% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	10.30%	CN¥1.45 Billion ≈ $211.76 Million	CN¥14.04 Billion ≈ $2.06 Billion	-6.78pp
2024-12-31	17.09%	CN¥2.51 Billion ≈ $367.30 Million	CN¥14.69 Billion ≈ $2.15 Billion	+1.46pp
2023-12-31	15.62%	CN¥2.46 Billion ≈ $359.30 Million	CN¥15.71 Billion ≈ $2.30 Billion	+3.25pp
2022-12-31	12.38%	CN¥2.01 Billion ≈ $293.92 Million	CN¥16.23 Billion ≈ $2.37 Billion	+11.80pp
2021-12-31	0.57%	CN¥40.39 Million ≈ $5.91 Million	CN¥7.05 Billion ≈ $1.03 Billion	-0.86pp
2020-12-31	1.44%	CN¥50.36 Million ≈ $7.37 Million	CN¥3.50 Billion ≈ $512.70 Million	-1.24pp
2019-12-31	2.68%	CN¥58.00 Million ≈ $8.49 Million	CN¥2.16 Billion ≈ $316.80 Million	+2.66pp
2018-12-31	0.02%	CN¥343.70K ≈ $50.29K	CN¥1.81 Billion ≈ $265.54 Million	-0.02pp
2017-12-31	0.04%	CN¥671.42K ≈ $98.25K	CN¥1.66 Billion ≈ $242.29 Million	0.00pp
2016-12-31	0.04%	CN¥619.72K ≈ $90.68K	CN¥1.45 Billion ≈ $212.83 Million	+0.02pp
2015-12-31	0.03%	CN¥301.31K ≈ $44.09K	CN¥1.10 Billion ≈ $161.20 Million	+0.02pp
2014-12-31	0.01%	CN¥64.47K ≈ $9.43K	CN¥805.50 Million ≈ $117.87 Million	-0.01pp
2013-12-31	0.02%	CN¥121.71K ≈ $17.81K	CN¥606.98 Million ≈ $88.82 Million	--

pp = percentage points

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$4.71 Billion

CN¥32.15 Billion CNY

Market Cap Rank

#3710 Global

#510 in China

Share Price

CN¥25.43

Change (1 day)

-2.79%

52-Week Range

CN¥25.43 - CN¥59.40

All Time High

CN¥142.90